参考文献/References:
[1].Fernandes CJ,Steigner ML,Piazza G,et al. Collaborative cardiology and pulmonary management of pulmonary hypertension[J]. Chest,2019,156(2):200-202.
[2].中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会.糖尿病心肌病病证结合诊疗指南(2021-12-31)[J]. 世界中医药,2022,17(12):1641-1653.
[3].张倩,卫晓红,陈洁,等.慢性心力衰竭常用动物模型的研究进展及其在中医药研究中的应用[J].中国中药杂志,2023,48(3):614-624.
[4].Ritchie RH,Abel ED. Basic mechanisms of diabetic heart disease[J]. Circ Res,2020,126(11):1501-1525.
[5].Audzeyenka I,Rachubik P,Typiak M,et al. Hyperglycemia alters mitochondrial respiration efficiency and mitophagy in human podocytes[J]. Exp Cell Res,2021,407(1):112758.
[6].Zhao X,Liu S,Wang X,et al. Diabetic cardiomyopathy:clinical phenotype and practice[J]. Front Endocrinol,2022,13:1032268.
[7].Yu R ,Liu T,Jin SB,et al. MIEF1/2 orchestrate mitochondrial dynamics through direct engagement with both the fission and fusion machineries[J]. BMC Biol,2021,19(1):229-230.
[8].Huang S,Li Z,Wu Z,et al. DDAH2 suppresses RLR-MAVS-mediated innate antiviral immunity by stimulating nitric oxide-activated,Drp1-induced mitochondrial fission[J]. Sci Signal,2021,14(678):eabc7931.
[9].Fajardo G,Coronado M,Matthews M,et al. Mitochondrial quality control in the heart:the balance between physiological and pathological stress[J]. Biomedicines,2022,10(6):1375.
[10].Noone J,O’Gorman DJ,Kenny HC. OPA1 regulation of mitochondrial dynamics in skeletal and cardiac muscle[J]. Trends Endocrinol Metab,2022,33(10):710-721.
[11].Bian W,Chen W,Nguyen T,et al. miR-199a overexpression enhances the potency of human induced-pluripotent stem-cell-derived cardiomyocytes for myocardial repair[J]. Front Pharmacol,2021,12:673621.
[12].Han S,Zhao F,Hsia J,et al. The role of Mfn2 in the structure and function of endoplasmic reticulum-mitochondrial tethering in vivo[J]. J Cell Sci,2021,134(13):jcs253443.
[13].Inagaki S,Suzuki Y,Kawasaki K,et al. Mitofusin 1 and 2 differentially regulate mitochondrial function underlying Ca2+ signaling and proliferation in rat aortic smooth muscle cells[J]. Biochem Biophys Res Commun,2023,645:137-146.
[14].胡朗. Mfn2介导的线粒体动力学障碍在糖尿病心肌病中的作用及分子机制[D].空军军医大学,2019.
[15].Morio A,Tsutsumi R,Kondo T,et al. Leucine induces cardioprotection in vitro by promoting mitochondrial function via mTOR and Opa-1 signaling[J]. Nutr Metab Cardiovasc Dis,2021,31(10):2979-2986.
[16].徐佳. 黄连素通过调控SIRT1/Opa1通路改善肝胰岛素抵抗的作用及机制研究[D].吉林:吉林大学,2020.
[17].Xu J,Zhang Y,Yu Z,et al. Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway[J]. Acta Biochim Biophys Sin,2022,54(10):1464-1475.
[18].Chehaitly A,Guihot AL,Proux C,et al. Altered mitochondrial Opa1-related fusion in mouse promotes endothelial cell dysfunction and atherosclerosis[J]. Antioxidants,2022,11(6):1078.
[19].Yu R,Jin SB,Ankarcrona M,et al. The molecular assembly state of Drp1 controls its association with the mitochondrial recruitment receptors Mff and MIEF1/2[J]. Front Cell Dev Biol,2021,9:706687.
[20].刘振华,刘银姬,牛津,等.U50,488H抑制心肌细胞缺氧/复氧诱导Drp1线粒体转位的作用及机制[J].心脏杂志,2020,32(6):565-571.
[21].Ostaszewska-Bugajska M,Podgórska A,Szal B. Markers for mitochondrial ROS status[J]. Methods Mol Biol,2022,2363:199-213.
[22].Bland AR,Payne FM,Ashton JC,et al. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury[J]. Pharmacol Res,2022,175:105986.
[23].Wu QR,Zheng DL,Liu PM,et al. High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy[J]. Cell Death Dis,2021,12(2):216.
[24].Alcántar-Fernández J,González-Maciel A,Reynoso-Robles R,et al. High-glucose diets induce mitochondrial dysfunction in Caenorhabditis elegans[J]. PloS One,2019,14(12):e0226652.
[25].Robson A. A novel cardioprotective function for DRP1 inhibition[J]. Nat Rev Cardiol,2021,18(5):306-307.
[26].Kim D,Sankaramoorthy A,Roy S. Downregulation of Drp1 and Fis1 inhibits mitochondrial fission and prevents high glucose-induced apoptosis in retinal endothelial cells[J]. Cells,2020,9(7):1662.
[27].Yang J,Chen P,Cao Y,et al. Chemical inhibition of mitochondrial fission via targeting the DRP1-receptor interaction[J]. Cell Chem Biol,2023,30(3):278-294.e11.
[28].刘小丽,廖达文,王星琛,等.BLOC-3介导Rab32线粒体定位改变对肝癌细胞生长的作用研究[J].中国癌症防治杂志,2023,15(2):129-137.
[29].宋元秀,崔鸣.线粒体动力学异常与相关心血管疾病[J].心血管病学进展,2021,42(2):162-166.
[30].Liu A,Kage F,Higgs HN. Mff oligomerization is required for Drp1 activation and synergy with actin filaments during mitochondrial division[J]. Mol Biol Cell,2021,32(20):ar5.
[31].Jin JY,Wei XX,Zhi XL,et al. Drp1-dependent mitochondrial fission in cardiovascular disease[J]. Acta Pharmacol Sin,2021,42(5):655-664.
[32].Sultan A,Jacobson M,Adeghate E,et al. Effects of obesity and diabesity on heart rhythm in the Zucker rat[J]. Clin Exp Pharmacol Physiol,2021,48(5):735-747.
[33].Gilkerson R,De La Torre P,St Vallier S. Mitochondrial OMA1 and OPA1 as gatekeepers of organellar structure/function and cellular stress response[J]. Front Cell Dev Biol,2021,9:626117.
[34].Fealy CE,Mulya A,Lai N,et al. Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle[J]. J appl physiol,2014,117(3):239-245.
[35].郑宏庭,瞿华. 线粒体动力学与糖尿病并发症发病机制[J]. 第三军医大学学报,2022,44(1):64-68.
[36].Lorenzo-Almorós A,Cepeda-Rodrigo JM,Lorenzo ?. Diabetic cardiomyopathy[J]. Rev Clin Esp,2022,222(2):100-111.
[37].Méndez-López I,Sancho-Bielsa FJ,Engel T,et al. Progressive mitochondrial SOD1G93A accumulation causes severe structural,metabolic and functional aberrations through OPA1 down-regulation in a mouse model of amyotrophic lateral sclerosis[J]. Int J Mol Sci,2021,22(15):8194.
[38].Ramzan R,Dolga AM,Michels S,et al. Cytochrome c oxidase inhibition by ATP decreases mitochondrial ROS production[J]. Cells,2022,11(6):992.
[39].Li H. Physiologic and pathophysiologic roles of AKAP12[J]. Sci Prog,2022,105(3):368504221109212.
[40].Yuan M,Gong M,Zhang Z,et al. Hyperglycemia induces endoplasmic reticulum stress in atrial cardiomyocytes,and mitofusin-2 downregulation prevents mitochondrial dysfunction and subsequent cell death[J]. Oxid Med Cell Longev,2020,2020:6569728.
[41].Zhi F,Zhang Q,Liu L,et al. Novel insights into the role of mitochondria in diabetic cardiomyopathy: molecular mechanisms and potential treatments[J].Cell Stress Chaperones,2023.DOI: 10.1007/s12192-023-01361-w.
相似文献/References:
[1]王静娜,侯瑞田,史亦男,等.糖尿病心肌病发病机制及病理改变研究进展[J].心血管病学进展,2016,(4):412.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.022]
WANG Jingna,HOU Ruitian,SHI Yinan,et al.Research Progress on Pathogenesis and Pathological Changes
of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2016,(12):412.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.022]
[2]杨沫,姜文锡.线粒体功能异常在糖尿病心肌病发病机制中的作用[J].心血管病学进展,2015,(6):731.[doi:10.3969/j.issn.1004-3934.2015.06.019]
YANG Mo,JIANG Wenxi.Mitochondrial Dysfunction of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2015,(12):731.[doi:10.3969/j.issn.1004-3934.2015.06.019]
[3]朱月红,戴启明.糖尿病心肌病的内质网病变机制及干预[J].心血管病学进展,2015,(6):738.[doi:10.3969/j.issn.1004-3934.2015.06.021]
ZHU Yuehong,DAI Qiming.Advance of Mechanism and Intervention of Endoplasmic Reticulum in
Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2015,(12):738.[doi:10.3969/j.issn.1004-3934.2015.06.021]
[4]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(12):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[5]武韧 常贵全 孙凤起 李鸿珠.硫化氢对糖尿病心肌病的保护作用[J].心血管病学进展,2021,(1):52.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
WU Ren,CHANG Guiquan,SUN Fengqi,et al.Protective Effect of Hydrogen Sulfide in Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(12):52.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[6]马韵之 李剑 周鹏.糖尿病心肌病血清生物标志物研究进展[J].心血管病学进展,2021,(5):392.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.002]
Serum Biomarkers of Diabetic Cardiomyopathy.[J].Advances in Cardiovascular Diseases,2021,(12):392.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.002]
[7]李艳鹏 马依彤.糖尿病心肌病治疗策略的研究进展[J].心血管病学进展,2022,(9):795.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.007]
LI Yanpeng,MA Yitong.Treatment Strategies for Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(12):795.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.007]
[8]曹兴丹 陈子仪 宋小刚 张玉秀 陈敏 汤吉超 李萍萍 陈永清 荆哲.EMRE在高糖环境中的变化对心肌细胞凋亡机制的研究[J].心血管病学进展,2022,(10):953.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.020]
CAO XingdanCHEN ZiyiSONG XiaogangZHANG YuxiuCHEN MinTANG JichaoLI PingpingCHEN YongqingJING Zhe.Effect of High Glucose-Induced EMRE Expressions Changes on?yocardial Apoptosis[J].Advances in Cardiovascular Diseases,2022,(12):953.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.020]
[9]林佳音 王莉莉 于小晴.胰高血糖素样肽-1受体激动剂对糖尿病心肌病的影响[J].心血管病学进展,2023,(11):1024.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.015]
LIN Jiayin,WANG Lili,YU Xiaoqing.Effect of Glucagon-Like Peptide-1 Receptor Agonist on Diabetes Cardiomyopathy[J].Advances in Cardiovascular Diseases,2023,(12):1024.[doi:10.16806/j.cnki.issn.1004-3934.2023.11.015]
[10]董泽耀 庄小密 鲁静.模式识别受体在糖尿病心肌病中的研究进展[J].心血管病学进展,2024,(6):548.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.016]
DONG Zeyao,ZHUANG Xiaomi,LU Jing?/html>.Research Progress of Pattern Recognition Receptors in?iabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2024,(12):548.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.016]
[11]宋元秀 崔鸣.线粒体动力学异常与相关心血管疾病[J].心血管病学进展,2021,(2):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
SONG Yuanxiu,CUI Ming.Correlation Between Mitochondrial Dynamics and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2021,(12):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]